SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,055 | +47.7% | 148,941 | +39.5% | 1.45% | +57.2% |
Q2 2023 | $12,226 | +598.6% | 106,760 | +740.6% | 0.92% | +701.7% |
Q1 2023 | $1,750 | +68.4% | 12,700 | +58.4% | 0.12% | +66.7% |
Q4 2022 | $1,039 | -99.8% | 8,019 | +110.7% | 0.07% | +137.9% |
Q3 2022 | $421,000 | -98.5% | 3,805 | -99.0% | 0.03% | -97.5% |
Q1 2021 | $27,659,000 | +111.2% | 371,107 | +383.2% | 1.18% | +101.5% |
Q4 2020 | $13,094,000 | -11.9% | 76,803 | -27.5% | 0.58% | -21.6% |
Q3 2020 | $14,870,000 | -32.3% | 105,886 | -22.7% | 0.74% | -47.4% |
Q2 2020 | $21,969,000 | +189.0% | 137,016 | +76.3% | 1.41% | +135.3% |
Q1 2020 | $7,601,000 | +171.6% | 77,701 | +258.3% | 0.60% | +249.4% |
Q4 2019 | $2,799,000 | +7464.9% | 21,689 | +4272.8% | 0.17% | +8500.0% |
Q3 2019 | $37,000 | +27.6% | 496 | +101.6% | 0.00% | +100.0% |
Q1 2019 | $29,000 | -21.6% | 246 | -27.9% | 0.00% | -50.0% |
Q4 2018 | $37,000 | – | 341 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |